COMMUNIQUÉS West-GlobeNewswire

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases
16/07/2026
CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2026 et fait le point sur ses activités
16/07/2026
Châtillon, France, le 16 juillet 2026 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2026 et fait le point sur ses activités Poursuite d’échanges productifs avec la FDA dans le cadre [...]
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
16/07/2026
Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testing Supports iMDx's commercial strategy in transplant monitoring Final policy establishes recurring testing baseline [...]
DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update
16/07/2026
Châtillon, France, July 16, 2026 DBV Technologies Reports Second Quarter and Half-Year 2026 Financial Results and Business Update Continued productive engagement with the FDA in support of the BLA for the VIASKIN® [...]
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
Canadian Red Cross supports communities impacted by Ottawa flooding
16/07/2026
Funds raised will help people affected by the floods with their recovery OTTAWA, Ontario, July 16, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is working closely with the City of Ottawa and community partners to [...]
EssilorLuxottica: Second-Quarter and First-Half 2026 Results Conference Call Invitation
16/07/2026
Second-Quarter and First-Half 2026 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial [...]
La Croix-Rouge canadienne vient en aide aux communautés frappées par les inondations à Ottawa
16/07/2026
Les sommes amassées soutiendront le rétablissement des personnes touchées par les inondations. OTTAWA, Ontario, 16 juill. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne travaille étroitement avec la Ville d’Ottawa [...]
Trethera and UCLA Publish Comprehensive Review Highlighting Deoxycytidine Kinase as a Novel Metabolic Target for Cancer Therapy
16/07/2026
Peer-reviewed publication positions TRE-515 as the first clinically tested dCK inhibitor and outlines a new therapeutic framework for targeting nucleotide metabolism in tumors LOS ANGELES, July 16, 2026 (GLOBE NEWSWIRE [...]
NativePath 2026: Launch Effective Native Path Creatine Supplements for Seniors To Support Muscle Building and Strength with L-Leucine in USA
16/07/2026
Announcing NativePath Creatine Supplement combines creatine monohydrate, L-leucine, and L-carnitine to support muscle strength, recovery, energy, and lean muscle growth for an active lifestyle and daily wellness routine [...]
Society for Medical Decision Making Honors UMIT TIROL and Harvard Professor Uwe Siebert with 2026 Career Achievement Award
16/07/2026
OSLO, Norway, July 16, 2026 (GLOBE NEWSWIRE) -- The Society for Medical Decision Making (SMDM) presented its highest career honor, the 2026 Career Achievement Award , to Professor Uwe Siebert, MPH, MSc, ScD , of UMIT [...]
Vericel to Report Second Quarter 2026 Financial Results on July 30, 2026
16/07/2026
BURLINGTON, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report [...]
Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions
16/07/2026
Osteoarthritic Pain Model Results Further Validate FABP5 as a Novel Therapeutic Target in Pain Management SOLANA BEACH, Calif., July 16, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the [...]
Rinascera Therapeutics Launches with Clinical-Stage Pipeline to Transform the Treatment of Genetic Skin Diseases
16/07/2026
- Initial financing led by Double Point Ventures with participation from Olive Tree Capital, Civilization Ventures and Toba Capital - - Supports advancement of RIN-001 for Gorlin Syndrome and RIN-002 for Dystrophic [...]
A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery
16/07/2026
Video: How does AMT’S ELANA® system work? The first suture-less, beating-heart bypass connection, shown to be safe with promising early effectiveness in a peer-reviewed clinical trial. AMT Medical reports one-year [...]
Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
16/07/2026
CONSHOHOCKEN, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its second-quarter 2026 financial results on Thursday, July 30, 2026, prior to the [...]
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
16/07/2026
SAN DIEGO, July 16, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety [...]
InnoCare Announces Phase II Study Results of TYK2 Inhibitor Soficitinib Meet Primary Endpoint in Patients with Vitiligo
16/07/2026
BEIJING, July 16, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Phase II [...]
Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
16/07/2026
PRINCETON, N.J., July 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2026 financial results on Wednesday, [...]

Pages